Abstract: An injector for injecting an IOL into an eye, comprising an injector body having a lumen wall defining a lumen, a plunger having a longitudinal axis and a soft tip at a distal end of the plunger. The soft tip having a concave distal surface. In a plane including the longitudinal axis, the plane being perpendicular to an IOL optical axis when the IOL is located at a staging area of the injector body, the concave distal surface extending in a direction at a non-perpendicular angle relative to the longitudinal axis. The concave distal surface may be oval-shaped in a plane perpendicular to the direction, and the concave distal surface has no curvature along the direction.

Abstract: An injector for injecting an IOL into an eye, comprising an injector body having a lumen wall defining a lumen, a plunger having a longitudinal axis and a soft tip at a distal end of the plunger. The soft tip having a concave distal surface. In a plane including the longitudinal axis, the plane being perpendicular to an IOL optical axis when the IOL is located at a staging area of the injector body, the concave distal surface extending in a direction at a non-perpendicular angle relative to the longitudinal axis. The concave distal surface may be oval-shaped in a plane perpendicular to the direction, and the concave distal surface has no curvature along the direction.

Abstract: An intraocular lens (“IOL”) cartridge includes an upper wall and a lower wall, together defining a lumen for receiving an IOL. The proximal end of the cartridge has an open slot cut into and through the entire thickness of the upper wall so to allow the leading haptic of the IOL to extend above the upper wall. The cartridge includes a proximal-end feature to facilitate folding of the leading haptic radially inward relative to the optic as the IOL moves into the lumen.

Abstract: A device for dispensing fluid to a patient enabling either or both of a continuous flow, as well as successive, large-volume boluses. A first reservoir provides a source of fluid under pressure. A bolus flow path provides for the delivery of a bolus dose of fluid and an optional continuous flow path provides a continuous flow rate of fluid. Both flow paths are in fluid communication with the source of fluid. A bolus delivery system in fluid communication with the bolus flow path receives fluid from the first reservoir, expands to pressurize fluid, stores the pressurized fluid, and dispenses the pressurized fluid while avoiding bolus refill until enabled to expand in a subsequent delivery cycle. An actuator releases fluid from the bolus delivery system such that when actuated by the patient, fluid is permitted to flow out of the bolus reservoir to the patient without further action by the patient.

Abstract: An IOL injector cartridge, comprising an upper wall, a lower wall, the upper wall and the lower wall combining to define a lumen that extends from a proximal end to a distal end, a slot extending through the entire thickness of the upper wall and extending from the proximal end and having a slot distal end formed by the upper wall, an edge of the upper wall that, at least partially defines the slot, having a convex curvature, the curvature occurring along the thickness of the edge.

Abstract: A patient controlled liquid drug administration device is provided that enables either or both of a continuous flow of a liquid drug, as well as successive, large-volume boluses thereof, to be self-administered to and by a patient while avoiding bolus refill during bolus delivery or after bolus delivery but before an intake stroke of the pump occurs. The device includes an elongated housing having an axial cavity extending through it with a reciprocating pump mounted at a bottom end thereof. The pump defines a closed internal reservoir and includes a first wall, or seat, that is fixed in the cavity, and a second, flexible wall that is axially movable in the cavity in relation to the fixed wall between reservoir-full and reservoir-empty positions. The pump includes an inlet port that is connectable to a source of a pressurized liquid drug by an inlet conduit, and an outlet port subcutaneously connectable to the patient by an outlet conduit, both conduits extending out the bottom end of the housing.

Abstract: A patient controlled liquid drug administration device is provided that enables either or both of a continuous flow of a liquid drug, as well as successive, large-volume boluses thereof, to be self-administered to and by a patient while avoiding bolus refill during bolus delivery or after bolus delivery but before an intake stroke of the pump occurs. The device includes an elongated housing having an axial cavity extending through it with a reciprocating pump mounted at a bottom end thereof. The pump defines a closed internal reservoir and includes a first wall, or seat, that is fixed in the cavity, and a second, flexible wall that is axially movable in the cavity in relation to the fixed wall between reservoir-full and reservoir-empty positions. The pump includes an inlet port that is connectable to a source of a pressurized liquid drug by an inlet conduit, and an outlet port subcutaneously connectable to the patient by an outlet conduit, both conduits extending out the bottom end of the housing.

Abstract: An apparatus that is used to perform a medical procedure on a cornea. The apparatus may include a ring that can be placed on a cornea and a probe that can deliver energy to denature corneal tissue. The probe can be moved about the ring and cornea by a first actuator. A second actuator may move the probe into contact with the cornea to deliver energy and denature tissue. The process of moving the probe and delivering energy can be repeated to create a circular pattern of denatured areas. The circular pattern of denatured areas may correct for hyperopia. The actuators may be controlled by a controller that operates in accordance with a program to move the probe and create the circular pattern of denatured areas in an automated process.

Abstract: An apparatus and method for treating superficial skin conditions with radio frequency energy. The apparatus includes a probe that is coupled to a radio frequency console. The probe has at least one tip that can be inserted into skin tissue. Radio frequency energy can be delivered to the skin tissue through the tip. The radio frequency energy denatures tissue to cause tissue shrinkage. The tissue shrinkage can reduce or remove wrinkles, or reduce or eliminate the visual appearance of blood carrying tissue such as facial spider veins.